SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-013502
Filing Date
2024-05-17
Accepted
2024-05-17 16:20:47
Documents
1
Period of Report
2024-05-16

Document Format Files

Seq Description Document Type Size
1 form4-05172024_080532.html 4  
1 form4-05172024_080532.xml 4 4453
  Complete submission text file 0001415889-24-013502.txt   5922
Mailing Address C/O ARCUTIS BIOTHERAPEUTICS, INC. 3027 TOWNSGATE ROAD, SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address
Moore Matthew Richard (Reporting) CIK: 0001840191 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 24960047

Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)